A Single Institution Experience with Weekly Intramuscular Methotrexate for Nonmetastatic Gestational Trophoblastic Disease

Author： Hoffman M.S. Fiorica J.V. Gleeson N.C. Roberts W.S. Cavanagh D.

Publisher： Academic Press

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.60, Iss.2, 1996-02, pp. : 292-294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Weekly Intravenous Methotrexate with Folinic Acid for Nonmetastatic Gestational Trophoblastic Neoplasia

By Kwon J.S. Elit L. Mazurka J. Moens F. Schmuck M.L.

Gynecologic Oncology, Vol. 82, Iss. 2, 2001-08 ,pp. : 367-370

Elsevier

Access to resources Recommend Favorite

Detection of β-Subunit Human Chorionic Gonadotropin mRNA in the Peripheral Blood of Patients with Nonmetastatic Gestational Trophoblastic Disease

By Suzuka K. Matsui H. Iitsuka Y. Sekiya S.

Gynecologic Oncology, Vol. 86, Iss. 1, 2002-07 ,pp. : 53-56

Academic Press

Access to resources Recommend Favorite

Subsequent Reproductive Experience after Treatment for Gestational Trophoblastic Disease

By Kim J.H. Park D.C. Bae S.N. Namkoong S.E. Kim S.J.

Gynecologic Oncology, Vol. 71, Iss. 1, 1998-10 ,pp. : 108-112

Elsevier

Access to resources Recommend Favorite

Experience with platinum-based and high-dose chemotherapy in patients with gestational trophoblastic disease: possible implications for future management

By Markman Maurie

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 7, 2004-07 ,pp. : 383-387

Springer Publishing Company

Access to resources Recommend Favorite

Is Lack of Response to Single-Agent Chemotherapy in Gestational Trophoblastic Disease Associated with Dose Scheduling or Chemotherapy Resistance?

By Kohorn E.I.

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 36-39

Elsevier

Access to resources Recommend Favorite